Sulforaphane accelerates acetaldehyde metabolism by inducing aldehyde dehydrogenases: Relevance to ethanol intolerance

Alcohol and Alcoholism

Volumn 48, Issue 5, 2013, Pages 526-534

  Ushida, Yusuke ^a,b   Talalay, Paul ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KAGOME CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETALDEHYDE; ALDEHYDE DEHYDROGENASE; ELECTROPHILE; KELCH LIKE ECH ASSOCIATED PROTEIN 1; SULFORAPHANE; TRANSCRIPTION FACTOR NRF2; ALCOHOL; ALDEHYDE DEHYDROGENASE 1A1; ALDEHYDE DEHYDROGENASE 3A1; ARE PROTEIN; FLAVONOID; GLUCOSINOLATE; NAD(P)H QUINONE ACCEPTOR OXIDOREDUCTASE 1; PROPIONALDEHYDE; PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); RESVERATROL; TRITERPENOID; UNCLASSIFIED DRUG;

ALCOHOL INTOLERANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DOWNSTREAM PROCESSING; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; HEPATOMA CELL; IN VIVO STUDY; MICHAEL ADDITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; VEGETABLE; ALCOHOL BLOOD LEVEL; ANTIOXIDANT RESPONSIVE ELEMENT; AREA UNDER THE CURVE; BODY WEIGHT; CELL LYSATE; CHEMICAL STRUCTURE; CONSENSUS SEQUENCE; DNA FLANKING REGION; DRUG METABOLISM; EMBRYO; ENZYME INDUCTION; FOOD INTAKE; FORESTOMACH; GENE EXPRESSION; LIVER; SMALL INTESTINE; STOMACH; TRANSCRIPTION INITIATION SITE;

ACETALDEHYDE; ALCOHOL DRINKING; ALDEHYDE DEHYDROGENASE; ANIMALS; CELL LINE, TUMOR; ENZYME INDUCTION; ETHANOL; FEMALE; ISOTHIOCYANATES; MICE; RANDOM ALLOCATION;

EID: 84882936506     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agt063     Document Type: Article

References (42)

1. Abdullah A, Kitteringham NR, Jenkins RE et al. (2012) Analysis of the role of Nrf2 in the expression of liver proteins in mice using two-dimensional gel-based proteomics. Pharmacol Rep 64:680-97.
2. Baird L, Dinkova-Kostova AT. (2011) The cytoprotective role of the Keap1-Nrf2 pathway. Arch Toxicol 85:241-72.
3. Brooks PJ, Enoch MA, Goldman D et al. (2009) The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption. PLoS Med 6:e50.
4. Cho HY, Reddy SP, Debiase A et al. (2005) Gene expression profiling of NRF2-mediated protection against oxidative injury. Free Radic Biol Med 38:325-43.
5. Crabb DW, Matsumoto M, Chang D et al. (2004) Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. Proc Nutr Soc 63:49-63.
6. Dinkova-Kostova AT, Abeygunawardana C, Talalay P. (1998) Chemoprotective properties of phenylpropenoids, bis(benzylidene) cycloalkanones, and related Michael reaction acceptors: correlation of potencies as phase 2 enzyme inducers and radical scavengers. J Med Chem 41:5287-96.
7. Dinkova-Kostova AT, Liby KT, Stephenson KK et al. (2005) Extremely potent triterpenoid inducers of phase 2 response: correlations of protection against oxidant and inflammatory stress. Proc Natl Acad Sci USA 102:4584-9.
8. Dinkova-Kostova AT, Talalay P, Sharkey J et al. (2010) An exceptionally potent inducer of cytoprotective enzymes: elucidation of the structural features that determine inducer potency and reactivity with Keap1. J Biol Chem 285:33747-55.
9. Elbarbry F, Elrody N. (2011) Potential health benefits of sulforaphane: a review of the experimental, clinical and epidemiological evidences and underlying mechanisms. J Med Plants Res 5:473-84.
10. Eng MY, Luczak SE, Wall TL. (2007) ALDH2, ADH1B, and ADH1C genotypes in Asians: a literature review. Alcohol Res Health 30:22-7.
11. Fahey JW, Dinkova-Kostova AT, Stephenson KK et al. (2004) The 'Prochaska' microtiter plate bioassay for inducers of NQO1. Methods Enzymol 382:243-58.
12. Fahey JW, Talalay P, Kensler TW. (2012) Notes from the field: 'green' chemoprevention as frugal medicine. Cancer Prev Res 5:179-88.
13. Guerrero-Beltrán CE, Calderón-Oliver M, Pedraza-Chaverri J et al. (2010) Protective effect of sulforaphane against oxidative stress: recent advances. Exp Toxicol Pathol 64:503-8.
14. Harada S, Agarwal DP, Goedde HW. (1981) Aldehyde dehydrogenase deficiency as cause of facial flushing reaction to alcohol in Japanese. Lancet 31:982.
15. Hayes JD, McMahon M, Chowdhry S et al. (2010) Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway. Antioxid Redox Signal 13:1713-48.
16. Healy ZR, Liu H, Holtzclaw WD et al. (2011) Inactivation of tautomerase activity of macrophage migration inhibitory factor by sulforaphane: a potential biomarker for anti-inflammatory intervention. Cancer Epidemiol Biomarkers Prev 20:1516-23.
17. Higdon JV, Delage B, Williams DE et al. (2007) Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacol Res 55:224-36.
18. Honda T, Sundararajan C, Yoshizawa H et al. (2007) Novel tricyclic compounds having acetylene groups at C-8a and cyano enones in rings A and C: highly potent anti-inflammatory and cytoprotective agents. J Med Chem 50:1731-4.
19. Impraim C, Wang G, Yoshida A. (1982) Structural mutation in a major human aldehyde dehydrogenase gene results in loss of enzyme activity. Am J Hum Genet 34:837-41.
20. Juge N, Mithen RF, Traka M. (2007) Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell Mol Life Sci 64:1105-27.
21. Kensler TW, Egner PA, Agyeman AS et al. (2013) Keap1-Nrf2 signaling: a target for cancer prevention by sulforaphane. Top Curr Chem 329:163-77.
22. Kitteringham NR, Abdullah A, Walsh J et al. (2010) Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liver. J Proteomics 73:1612-31.
23. Koivula T, Koivusalo M, Lindros KO. (1975) Liver aldehyde and alcohol dehydrogenase activities in rat strains genetically selected for their ethanol preference. Biochem Pharmacol 24:1807-11.
24. Lamlé J, Marhenke S, Borlak J et al. (2008) Nuclear factor-eythroid 2-related factor 2 prevents alcohol-induced fulminant liver injury. Gastroenterology 134:1159-68.
25. Lee JM, Calkins MJ, Chan K et al. (2003) Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J Biol Chem 278:12029-38.
26. Levi BP, Yilmaz OH, Duester G et al. (2009) Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems. Blood 113:1670-80.
27. Liu H, Dinkova-Kostova AT, Talalay P. (2008) Coordinate regulation of enzyme markers for inflammation and for protection against oxidants and electrophiles. Proc Natl Acad Sci USA 105:15926-231.
28. Nair S, Xu C, Shen G et al. (2006) Pharmacogenomics of phenolic antioxidant butylated hydroxyanisole (BHA) in the small intestine and liver of Nrf2 knockout and C57BL/6J mice. Pharm Res 23:2621-37.
29. Oze I, Matsuo K, Wakai K et al. (2011) Alcohol drinking and esophageal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 41:677-92.
30. Prochaska HJ, Santamaria AB. (1988) Direct measurement of NADPH: quinone reductase from cells cultured in microtiter wells: a screening assay for anticarcinogenic enzyme inducers. Anal Biochem 169:328-36.
31. Shen G, Xu C, Hu R et al. (2005) Comparison of (-)-epigallocatechin- 3-gallate elicited liver and small intestine gene expression profiles between C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice. Pharm Res 22:1805-20.
32. Sreerama L, Sládek NE. (2001) Three different stable human breast adenocarcinoma sublines that overexpress ALDH3A1 and certain other enzymes, apparently as a consequence of constitutively upregulated gene transcription mediated by transactivated EpREs (electrophile responsive elements) present in the 5-upstream regions of these genes. Chem Biol Interact 130-132:247-60.
33. Suganuma H, Fahey JW, Bryan KE et al. (2011) Stimulation of phagocytosis by sulforaphane. Biochem Biophys Res Commun 405:146-51.
34. Talalay P, Fahey JW. (2001) Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism. J Nutr 131:3027S-33S.
35. Talalay P, Fahey JW, Holtzclaw WD et al. (1995) Chemoprotection against cancer by phase 2 enzyme induction. Toxicol Lett 82- 83:173-9.
36. Talalay P, Dinkova-Kostova AT, Holtzclaw WD. (2003) Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis. Adv Enzyme Regul 43:121-34.
37. Tottmar O, Marchner H, Pettersson H. (1978) Determination of acetaldehyde in rat blood by the use of rat liver aldehyde dehydrogenase. Anal Biochem 91:241-9.
38. Vasiliou V, Pappa A, Estey T. (2004) Role of human aldehyde dehydrogenases in endobiotic and xenobiotic metabolism. Drug Metab Rev 36:279-99.
39. Yamaji T, Inoue M, Sasazuki S et al. (2008) Fruit and vegetable consumption and squamous cell carcinoma of the esophagus in Japan: the JPHC study. Int J Cancer 15:1935-40.
40. Yokoyama T, Yokoyama A, Kato H et al. (2003) Alcohol flushing, alcohol and aldehyde dehydrogenase genotypes, and risk for esophageal squamous cell carcinoma in Japanese men. Cancer Epidemiol Biomarkers Prev 12:1227-33.
41. Yoshida A, Huang IY, Ikawa M. (1984) Molecular abnormality of an inactive aldehyde dehydrogenase variant commonly found in Orientals. Proc Natl Acad Sci USA 81:258-61.
42. Zhang Y, Talalay P, Cho CG et al. (1992) A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci USA 89:2399-403.